NYC Passport #81626Y0811

NYC DOHMH Solicitation for Valent BioSciences Larvicide Mosquito Control Products

This opportunity involves a six-year procurement by the New York City Department of Health and Mental Hygiene (DOHMH) for larvicide mosquito control products to mitigate mosquito-borne diseases. - Government Buyer: - New York City Department of Health and Mental Hygiene (DOHMH) - Division of Environmental Health - OEMs and Vendors: - Valent BioSciences Corporation (OEM/manufacturer of all required larvicide products) - ADAPCO LLC (sole authorized distributor) - Products Requested: - VectoBac (larvicide) - VectoLex (larvicide) - VectoMax (larvicide) - VectoPrime (larvicide) - All products are manufactured by Valent BioSciences Corporation - No specific part numbers or quantities provided - Services: - Application of larvicides, pesticide spraying, public education, and investigation of standing water complaints - Unique/Notable Requirements: - Only Valent BioSciences products are acceptable - ADAPCO LLC is the exclusive authorized distributor - Estimated contract value is $5,000,000 - Open to expressions of interest from firms legally able to provide these goods - Place of Performance: - New York City, NY (DOHMH facilities) - Purpose: - Reduce risk of West Nile, Zika, and other mosquito-borne diseases through targeted mosquito control measures

Description

The Department of Health and Mental Hygiene (DOHMH) of New York City intends to negotiate a six-year agreement with ADAPCO LLC for larvicide mosquito control products. These products are essential for controlling mosquito populations to reduce the spread of diseases such as West Nile and Zika. Valent BioSciences Corporation is the sole manufacturer of the specified products, and ADAPCO LLC is the sole authorized distributor. The contract period is from July 1, 2026, to June 30, 2032, with an estimated value of $5,000,000. Vendors interested in providing these goods are invited to submit an Expression of Interest by April 2, 2026.

View original listing